{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T21:30:05Z","timestamp":1793568605396,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010698","name":"Landsforeningen for Hjerte- og Lungesyke","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100010698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012266","name":"Norwegian Rheumatism Association","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100012266","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Marit Hansens Memorial Fund","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Odd Fellow Norway","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Raagholt Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1945-4","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T14:03:15Z","timestamp":1561471395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Survival and death causes of patients with giant cell arteritis in Western Norway 1972\u20132012: a retrospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5599-2498","authenticated-orcid":false,"given":"L. K.","family":"Brekke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.-T. S.","family":"Fevang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P.","family":"Diamantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Assmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Esper\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. G.","family":"Gjesdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"issue":"9634","key":"1945_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","volume":"372","author":"C Salvarani","year":"2008","unstructured":"Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372(9634):234\u201345.","journal-title":"Lancet"},{"issue":"5","key":"1945_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/1744666X.2018.1467758","volume":"14","author":"TA Kermani","year":"2018","unstructured":"Kermani TA, Warrington KJ. Prognosis and monitoring of giant cell arteritis and associated complications. Expert Rev Clin Immunol. 2018;14(5):379\u201388.","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"1945_CR3","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.autrev.2017.05.014","volume":"16","author":"M Samson","year":"2017","unstructured":"Samson M, Corbera-Bellalta M, Audia S, Planas-Rigol E, Martin L, Cid MC, et al. Recent advances in our understanding of giant cell arteritis pathogenesis. Autoimmun Rev. 2017;16(8):833\u201344.","journal-title":"Autoimmun Rev"},{"key":"1945_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fimmu.2018.00315","volume":"9","author":"R Hid Cadena","year":"2018","unstructured":"Hid Cadena R, Abdulahad WH, Hospers GAP, Wind TT, Boots AMH, Heeringa P, et al. Checks and balances in autoimmune Vasculitis. Front Immunol. 2018;9:315.","journal-title":"Front Immunol"},{"issue":"2","key":"1945_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.semarthrit.2016.05.009","volume":"46","author":"MS Broder","year":"2016","unstructured":"Broder MS, Sarsour K, Chang E, Collinson N, Tuckwell K, Napalkov P, et al. Corticosteroid-related adverse events in patients with giant cell arteritis: a claims-based analysis. Semin Arthritis Rheum. 2016;46(2):246\u201352.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"1945_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.semarthrit.2016.11.006","volume":"46","author":"JC Wilson","year":"2017","unstructured":"Wilson JC, Sarsour K, Collinson N, Tuckwell K, Musselman D, Klearman M, et al. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): a nested case-control analysis. Semin Arthritis Rheum. 2017;46(6):819\u201327.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"1945_CR7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.semarthrit.2016.10.001","volume":"46","author":"JC Wilson","year":"2017","unstructured":"Wilson JC, Sarsour K, Collinson N, Tuckwell K, Musselman D, Klearman M, et al. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis. Semin Arthritis Rheum. 2017;46(5):650\u20136.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"1945_CR8","first-page":"1283","volume":"21","author":"G Nesher","year":"1994","unstructured":"Nesher G, Sonnenblick M, Friedlander Y. Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. J Rheumatol. 1994;21(7):1283\u20136.","journal-title":"J Rheumatol"},{"issue":"4","key":"1945_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.semarthrit.2016.08.015","volume":"46","author":"CL Hill","year":"2017","unstructured":"Hill CL, Black RJ, Nossent JC, Ruediger C, Nguyen L, Ninan JV, et al. Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2017;46(4):513\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"1945_CR10","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s00393-018-0440-7","volume":"77","author":"YH Lee","year":"2018","unstructured":"Lee YH, Song GG. Overall and cause-specific mortality in giant cell arteritis : a meta-analysis. Z Rheumatol. 2018;77(10):946\u201351.","journal-title":"Z Rheumatol"},{"issue":"2","key":"1945_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1365-2796.1991.tb00418.x","volume":"230","author":"C Bisgard","year":"1991","unstructured":"Bisgard C, Sloth H, Keiding N, Juel K. Excess mortality in giant cell arteritis. J Intern Med. 1991;230(2):119\u201323.","journal-title":"J Intern Med"},{"issue":"2","key":"1945_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/art.20227","volume":"51","author":"C Salvarani","year":"2004","unstructured":"Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum. 2004;51(2):264\u20138.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1945_CR13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/rheumatology\/key028","volume":"57","author":"A Aouba","year":"2018","unstructured":"Aouba A, Gonzalez Chiappe S, Eb M, Delmas C, de Boysson H, Bienvenu B, et al. Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate database (1980-2011). Rheumatology (Oxford). 2018;57(6):1047\u201355.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"1945_CR14","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/acr.23538","volume":"70","author":"L Li","year":"2018","unstructured":"Li L, Neogi T, Jick S. Mortality in patients with giant cell arteritis: a cohort study in UK primary care. Arthritis Care Res (Hoboken). 2018;70(8):1251\u20136.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"1945_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/gerona\/gln030","volume":"64","author":"RW Crow","year":"2009","unstructured":"Crow RW, Katz BJ, Warner JE, Alder SC, Zhang K, Schulman S, et al. Giant cell arteritis and mortality. J Gerontol A Biol Sci Med Sci. 2009;64(3):365\u20139.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"1945_CR16","first-page":"737","volume":"29","author":"A Uddhammar","year":"2002","unstructured":"Uddhammar A, Eriksson AL, Nystrom L, Stenling R, Rantapaa-Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol. 2002;29(4):737\u201342.","journal-title":"J Rheumatol"},{"issue":"11","key":"1945_CR17","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/rheumatology\/40.11.1238","volume":"40","author":"JT Gran","year":"2001","unstructured":"Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology (Oxford). 2001;40(11):1238\u201342.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1945_CR18","first-page":"2171","volume":"24","author":"MA Gonzalez-Gay","year":"1997","unstructured":"Gonzalez-Gay MA, Blanco R, Abraira V, Garcia-Porrua C, Ibanez D, Garcia-Pais MJ, et al. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol. 1997;24(11):2171\u20136.","journal-title":"J Rheumatol"},{"issue":"2","key":"1945_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0002-9343(97)89458-2","volume":"100","author":"EL Matteson","year":"1996","unstructured":"Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med. 1996;100(2):193\u20136.","journal-title":"Am J Med"},{"issue":"6","key":"1945_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3109\/03009749309095141","volume":"22","author":"SA Rajala","year":"1993","unstructured":"Rajala SA, Ahvenainen JE, Mattila KJ, Saarni MI. Incidence and survival rate in cases of biopsy-proven temporal arteritis. Scand J Rheumatol. 1993;22(6):289\u201391.","journal-title":"Scand J Rheumatol"},{"issue":"6698","key":"1945_CR21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1136\/bmj.299.6698.549","volume":"299","author":"E Nordborg","year":"1989","unstructured":"Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ. 1989;299(6698):549\u201350.","journal-title":"BMJ"},{"issue":"3","key":"1945_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/art.1780300308","volume":"30","author":"P Boesen","year":"1987","unstructured":"Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985. Arthritis Rheum. 1987;30(3):294\u20139.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1945_CR23","first-page":"595","volume":"103","author":"T Fjermestad","year":"1983","unstructured":"Fjermestad T. Temporal arteritis. A prospective study with special reference to the course of the disease. Tidsskr Nor Laegeforen. 1983;103(6):595\u20136.","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"6260","key":"1945_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/bmj.282.6260.269","volume":"282","author":"E Graham","year":"1981","unstructured":"Graham E, Holland A, Avery A, Russell RW. Prognosis in giant-cell arteritis. Br Med J (Clin Res Ed). 1981;282(6260):269\u201371.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"1945_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/003693307902400203","volume":"24","author":"F Jonasson","year":"1979","unstructured":"Jonasson F, Cullen JF, Elton RA. Temporal arteritis. A 14-year epidemiological, clinical and prognostic study. Scott Med J. 1979;24(2):111\u20137.","journal-title":"Scott Med J"},{"issue":"2","key":"1945_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.7326\/0003-4819-88-2-162","volume":"88","author":"KA Huston","year":"1978","unstructured":"Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978;88(2):162\u20137.","journal-title":"Ann Intern Med"},{"issue":"10","key":"1945_CR27","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.3899\/jrheum.101254","volume":"38","author":"J Ninan","year":"2011","unstructured":"Ninan J, Nguyen AM, Cole A, Rischmueller M, Dodd T, Roberts-Thomson P, et al. Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study. J Rheumatol. 2011;38(10):2215\u20137.","journal-title":"J Rheumatol"},{"key":"1945_CR28","unstructured":"Population in municipalities. Annual, as per January 1. Statistics Norway. [Internet. Accessed 26 Nov 2018.] Available from: \n                    https:\/\/www.ssb.no\/befolkning\/statistikker\/folkemengde\/aar-per-1-januar\/2018"},{"issue":"1","key":"1945_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13075-017-1479-6","volume":"19","author":"LK Brekke","year":"2017","unstructured":"Brekke LK, Diamantopoulos AP, Fevang BT, Abetamus J, Espero E, Gjesdal CG. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study. Arthritis Res Ther. 2017;19(1):278.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"1945_CR30","doi-asserted-by":"publisher","first-page":"768","DOI":"10.4045\/tidsskr.14.1065","volume":"135","author":"AG Pedersen","year":"2015","unstructured":"Pedersen AG, Ellingsen CL. Datakvalitet i d\u00f8ds\u00e5rsaksregisteret. Tidsskr Nor Laegeforen. 2015;135(8):768\u201370.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"1945_CR31","unstructured":"OECD glossary of statistical terms - underlying cause of death. [Internet. Accessed 26 Nov 2018.] Available from: \n                    https:\/\/stats.oecd.org\/glossary\/detail.asp?\n                    \n                   ID=2790."},{"key":"1945_CR32","unstructured":"R Core Team (2018). R: a language and environment for statistical computing. Vienna, Austria. [Internet. Accessed 16 Jan 2019.] Available from: \n                    https:\/\/www.R-project.org\/"},{"issue":"4","key":"1945_CR33","first-page":"506","volume":"56","author":"C Dejaco","year":"2017","unstructured":"Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford). 2017;56(4):506\u201315.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1945_CR34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/acr.22942","volume":"69","author":"M Catanoso","year":"2017","unstructured":"Catanoso M, Macchioni P, Boiardi L, Muratore F, Restuccia G, Cavazza A, et al. Incidence, prevalence, and survival of biopsy-proven giant cell arteritis in northern Italy during a 26-year period. Arthritis Care Res (Hoboken). 2017;69(3):430\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1945_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/rheumatology\/keu303","volume":"54","author":"B Baslund","year":"2015","unstructured":"Baslund B, Helleberg M, Faurschou M, Obel N. Mortality in patients with giant cell arteritis. Rheumatology (Oxford). 2015;54(1):139\u201343.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1945_CR36","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1136\/annrheumdis-2013-204652","volume":"74","author":"AJ Mohammad","year":"2015","unstructured":"Mohammad AJ, Nilsson JA, Jacobsson LT, Merkel PA, Turesson C. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden. Ann Rheum Dis. 2015;74(6):993\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1945_CR37","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","volume":"72","author":"TA Kermani","year":"2013","unstructured":"Kermani TA, Warrington KJ, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, et al. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis. 2013;72(12):1989\u201394.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1945_CR38","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/rheumatology\/key325","volume":"58","author":"Pierluigi Macchioni","year":"2018","unstructured":"Macchioni P, Boiardi L, Muratore F, Restuccia G, Cavazza A, Pipitone N, et al. Survival predictors in biopsy-proven giant cell arteritis: a northern Italian population-based study. Rheumatology (Oxford). 2018. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/key325\n                    \n                  .","journal-title":"Rheumatology"},{"issue":"5","key":"1945_CR39","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","volume":"77","author":"C Dejaco","year":"2018","unstructured":"Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77(5):636\u201343.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1945_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/rheumatology\/keu329","volume":"54","author":"F Muratore","year":"2015","unstructured":"Muratore F, Kermani TA, Crowson CS, Green AB, Salvarani C, Matteson EL, et al. Large-vessel giant cell arteritis: a cohort study. Rheumatology (Oxford). 2015;54(3):463\u201370.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"1945_CR41","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/rheumatology\/key325","volume":"58","author":"P Macchioni","year":"2019","unstructured":"Macchioni P, Boiardi L, Muratore F, Restuccia G, Cavazza A, Pipitone N, et al. Survival predictors in biopsy-proven giant cell arteritis: a northern Italian population-based study. Rheumatology (Oxford). 2019;58(4):609\u201316.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"1945_CR42","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122\u20138.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1945_CR43","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/rheumatology\/kex075","volume":"56","author":"B Seeliger","year":"2017","unstructured":"Seeliger B, Sznajd J, Robson JC, Judge A, Craven A, Grayson PC, et al. Are the 1990 American College of Rheumatology vasculitis classification criteria still valid? Rheumatology (Oxford). 2017;56(7):1154\u201361.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1945_CR44","first-page":"753","volume":"56","author":"L Li","year":"2017","unstructured":"Li L, Neogi T, Jick S. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. Rheumatology (Oxford). 2017;56(5):753\u201362.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1945_CR45","doi-asserted-by":"publisher","DOI":"10.7326\/M12-3046","volume":"160","author":"G Tomasson","year":"2014","unstructured":"Tomasson G, Peloquin C, Mohammad A, Love TJ, Zhang Y, Choi HK, et al. Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study. Ann Intern Med. 2014;160(2):73-80.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1945_CR46","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrrheum.2014.38","volume":"10","author":"SL Mackie","year":"2014","unstructured":"Mackie SL, Dasgupta B. Vasculitis syndromes: dealing with increased vascular risk and mortality in GCA. Nat Rev Rheumatol. 2014;10(5):264\u20135.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1945-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T23:12:25Z","timestamp":1592953945000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1945-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1945"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1945-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the REK s\u00f8r-\u00f8st B regional ethics committee (REC), which approved the study for all the hospitals involved (study reference number 2012\/643\/REK s\u00f8r-\u00f8st B). REC granted permission to access records without obtaining consent from patients or their relatives due to the long duration of the study and late onset of the disease. REC also granted permission to obtain a control cohort (3:1) matched on age, sex, and geography from the CPRN.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}